It was a busy week for the Contemporary OB/GYN® team.
This week's top articles included:
A webinar held by the Kaiser Family Foundation (KFF) in April shared highlights from the 2020 Women’s Health Survey, followed by a panel discussion on its implications in several areas. This article captures the discussion portion of the webinar.
“GO MOMs will set the foundation for determining future approaches to the screening, diagnosis, and eventually, the treatment of elevated blood glucose during pregnancy,” said NIDDK program director Barbara Linder, MD, PHD, the project scientist for the study.
Join Senior Editor Angie DeRosa as Sarah J. Kilpatrick, MD, PhD; and Christian M. Pettker, MD debate noun use. Should ob/gyns use the terms, "pregnant women" or "pregnant persons?" Let us know what you think via Twitter @ContempOBGYN.
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More